Pfizer applies for Japenese approval for COVID vaccine
Tokyo: Drugmaker Pfizer Inc said on Friday it had applied for approval in Japan for its COVID-19 vaccine, which is already being administered in the United Kingdom and the United States.
The Japanese government has a supply deal with Pfizer for 120 million doses of the vaccine made by the U.S. drugmaker and German partner BioNTech.
Pfizer said in a statement it had made the application to Japan's Health Ministry, along with providing information on tests it has carried out up to now.
A final decision on approval would be made after authorities examine data due in February from Pfizer's trials in Japan, Health Minister Norihisa Tamura was quoted by Jiji News as saying.
Read also: DCGI seeking more data for authorization will not impact Covid-19 vaccine roll-out timeline: Govt
Japan has said it wants all its residents vaccinated in the first half of 2021, although Tamura said whether or not to get the vaccine was ultimately up to each individual, Jiji reported.
Read also: Pfizer to price Covid-19 vaccine at 'little out-of-pocket expenses' for Indians
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.